Soligenix Inc (SNGX)

Jun 06, 2025

Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise - GuruFocus

Jun 06, 2025

Jun 06, 2025

Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials - GlobeNewswire

Jun 06, 2025

Jun 04, 2025

Soligenix Inc. (SNGX) Showcases Promising HyBryte Results in CTCL Treatment Through New Podcast - citybuzz -

Jun 04, 2025

Jun 04, 2025

Soligenix (NASDAQ: SNGX) Highlights HyBryte Progress in CTCL via New Podcast Featuring Dr. Ellen Kim - Barchart.com

Jun 04, 2025

May 27, 2025

Soligenix (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics - Barchart.com

May 27, 2025

May 27, 2025

Vaccine Contract Manufacturing Market Is Booming Worldwide | - openPR.com

May 27, 2025

May 23, 2025

Soligenix’s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results In Rare Cancer Trial - Barchart.com

May 23, 2025

May 23, 2025

Stocks in play: Brookfield Corporation - The Globe and Mail

May 23, 2025

May 23, 2025

Soligenix’s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare Cancer Trial - The Globe and Mail

May 23, 2025

May 22, 2025

Chemung Financial Corporation Announces Quarterly Dividend - The Globe and Mail

May 22, 2025

May 22, 2025

Soligenix’s HyBryte Shows Promise in Rare Cancer Treatment - citybuzz -

May 22, 2025

May 20, 2025

Soligenix (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results - The Globe and Mail

May 20, 2025

May 20, 2025

/R E P E A T -- Scotiabank to Announce Second Quarter 2025 Results/ - The Globe and Mail

May 20, 2025

May 20, 2025

Public market insider selling at Sprott (SII) - The Globe and Mail

May 20, 2025

May 19, 2025

Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com | FinancialContent - FinancialContent

May 19, 2025

May 18, 2025

Zacks Small Cap Predicts Reduced Earnings for Soligenix - Defense World

May 18, 2025

May 16, 2025

Zacks Research Issues Business Update as Soligenix (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial - The Globe and Mail

May 16, 2025

May 16, 2025

Oral Mucositis Drugs Market Set to Witness Significant Growth - openPR.com

May 16, 2025

May 15, 2025

SNGX: Enrollment Continues in Confirmatory Phase 3 Trial of HyBryte™ in CTCL… - MSN

May 15, 2025

May 15, 2025

Soligenix Reports Q1 2025 Financial Results and Milestones - TipRanks

May 15, 2025

May 13, 2025

SNGX: Enrollment Continues in Confirmatory Phase 3 Trial of HyBryte in CTCL - Research Tree

May 13, 2025

May 12, 2025

Contrasting Schrödinger (NASDAQ:SDGR) and Soligenix (NASDAQ:SNGX) - Defense World

May 12, 2025

May 10, 2025

Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results - Nasdaq

May 10, 2025

May 09, 2025

Soligenix Announces Recent Accomplishments And First Quarter 202 - GuruFocus

May 09, 2025

May 07, 2025

Soligenix (NASDAQ: SNGX) CEO Highlights Pipeline and Strategy in BioMedWire Podcast Episode - The Globe and Mail

May 07, 2025

May 07, 2025

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Christopher Schaber, CEO of Soligenix Inc. - The Manila Times

May 07, 2025

May 05, 2025

Geode Capital Management LLC Has $71,000 Stake in Soligenix, Inc. (NASDAQ:SNGX) - Defense World

May 05, 2025

May 02, 2025

Soligenix (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer - Barchart.com

May 02, 2025

May 02, 2025

Soligenix (SNGX) Projected to Post Quarterly Earnings on Friday - Defense World

May 02, 2025

Apr 30, 2025

Soligenix (NASDAQ: SNGX) Moves Forward To Strengthen The Case For HyBryte(TM) - Barchart.com

Apr 30, 2025

Apr 30, 2025

Soligenix (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM) - The Globe and Mail

Apr 30, 2025

Apr 25, 2025

U.S. Severe Oral Mucositis Market Projected To Witness - openPR.com

Apr 25, 2025

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 24, 2025

Soligenix reports positive results in skin cancer treatment trial By Investing.com - Investing.com India

Apr 24, 2025

Apr 24, 2025

Fireside Chat with Christopher Schaber, Chief Executive Officer of Soligenix, Inc. - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

Soligenix reports positive results in skin cancer treatment trial - Investing.com Australia

Apr 24, 2025

Apr 24, 2025

Solgenix shares rise on positive skin cancer treatment results By Investing.com - Investing.com Canada

Apr 24, 2025

Apr 24, 2025

Soligenix's HyBryte(TM) Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding - The Globe and Mail

Apr 24, 2025

Apr 23, 2025

EQS-News: Soligenix's HyBryte(TM) Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding - markets.businessinsider.com

Apr 23, 2025

Apr 22, 2025

Soligenix (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat - Barchart.com

Apr 22, 2025

Apr 15, 2025

Soligenix (NASDAQ: SNGX) Announces Positive Data, Continued Advancement of HyBryte(TM) - The Globe and Mail

Apr 15, 2025

Apr 15, 2025

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ f - GuruFocus

Apr 15, 2025

Apr 14, 2025

SNGX: Updated IIS Data Shows 75% Response Rate and Three Complete Responses… - MSN

Apr 14, 2025

Apr 14, 2025

Soligenix Announces Positive Data For Extended HyBryte In Early-stage Cutaneous T-cell Lymphoma - Nasdaq

Apr 14, 2025